Patents
Patents for C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
04/2004
04/08/2004WO2004029672A2 Transient optical state change materials useful in copy-protected compact discs
04/08/2004WO2004028538A1 Small organic molecules that increase the activity of gelatinase a in ocular cells
04/08/2004US20040068017 Small organic molecules that increase the activity of Gelatinase A in ocular cells
04/08/2004CA2503684A1 Transient optical state change materials useful in copy-protected compact discs
04/08/2004CA2500200A1 Small organic molecules that increase the activity of gelatinase a in ocular cells
04/07/2004EP1404340A1 Naphtothiazine positive allosteric ampa receptor modulators (paarm)
04/07/2004CN1144794C Benzoxazine and benzothiazine derivatives and their application in medicines
04/06/2004US6716833 Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
04/06/2004US6716832 Arylphenyl-substituted cyclic ketoenols
04/06/2004CA2067381C Treatment of hiv infections and compounds useful therein
04/01/2004US20040063696 Antiinflammatories targeting cartilage tissue; limiting side effects; arthritis, arthrosis
03/2004
03/31/2004CN1143851C Penicillene compounds and derivatives therefrom
03/30/2004US6713477 1,4-benzthiazines or benzoxazines; matrix metalloproteinase inhibitors
03/25/2004US20040059109 Alanine 2, 6-dialkoxyphenyl ester derivatives as hypnotics
03/24/2004EP1399421A1 Substituted imidates as pesticidal agents
03/24/2004EP1212119B1 USE OF CYAMEMAZINE FOR the treatment of abrupt benzodiazepine withdrawal
03/23/2004US6710062 Fungicidal compound having a cyanomethylene group bonded to the 2- position on the thiazolidine ring
03/18/2004WO2003026563A3 Conjugated anti-psychotic drugs and uses thereof
03/18/2004US20040054009 Useful for potentiating glutamate receptor function in a mammal and therefore useful for treating wide variety of conditions such as psychiatric and neurological disorders
03/18/2004US20040053920 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor
03/17/2004EP1397172A1 Safety shield system for prefilled syringes
03/17/2004EP1397170A1 Safety shield system for prefilled syringes
03/17/2004CN1142174C Optical information gene material and its application in gene chip technology
03/16/2004CA2096460C Dual action inhibitors
03/11/2004WO2002075318A3 Neurofibrillary labels
03/11/2004US20040048856 Monoamine reuptake inhibitors for treatment of CNS disorders
03/11/2004US20040048852 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
03/10/2004EP1395243A2 Encapsulation of nanosuspensions in liposomes and microspheres
03/10/2004CN1481372A 1,1-dioxo-2H-1,2-benzothiazine-3-carboxamide derivatives, method for preparing same and pharmaceutical compsns comprising same
03/09/2004US6703388 Dibenzodiazepine derivatives; antihistamines, leukotriene inhibitors, antiallergens, antiasthmatics; hay fever, atopic dermatitis, and urticaria treatment
03/04/2004WO2004018428A1 Antibacterial benzoic acid derivatives
03/04/2004WO2004018415A1 Sulfonamide derivatives, insecticides for agricultural and horticultural use, and usage thereof
03/04/2004WO2004018414A2 Antibacterial agents
03/04/2004US20040044226 Estrogen receptor modulators
03/04/2004US20040043985 6,6-Fused heteroaryl derivatives as matrix metalloproteinase inhibitors
03/04/2004US20040043984 3,4-Dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors
03/03/2004EP1392666A1 Biologically active methylene blue derivatives
03/03/2004EP1392639A1 Pyruvate derivatives
02/2004
02/26/2004WO2003062388A3 Inhibition of rna function
02/26/2004WO2002101003A3 Stereoselective preparation of cyclic l-amino acids
02/26/2004US20040039043 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials
02/25/2004EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials
02/25/2004CN1139586C Process for stereoselective preparation of hetero-bicyclic alcohol enantiomer
02/24/2004US6696494 α-hydroxyarylbutanamine inhibitors of aspartyl protease
02/24/2004CA2302727C Process for preparing cyclic thioamides
02/19/2004WO2004014389A1 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors
02/19/2004WO2004014388A1 6,6-fused heteroaryl derivatives as matrix metalloproteinase inhibitors
02/19/2004US20040034018 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
02/19/2004US20040033988 Sulfur compounds such as 2-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-N-hydroxy-3-methyl -butyramide, used as tumor necrosis factor-alpha converting enzyme (TACE) inhibitors, for prophylaxis of rheumatic diseases, sepsis or inflammation
02/17/2004US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia
02/17/2004US6692975 Compounds for use in the detection of preferential particles in sample
02/17/2004CA2152410C Mediators suitable for the electrochemical regeneration of nadh, nadph or analogs thereof
02/12/2004WO2004013113A1 Substituted thiazines as material protecting agents
02/12/2004WO2004013111A1 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers
02/12/2004DE10234425A1 Substituierte Thiazine als Materialschutzmittel Substituted Thiazines as a material preservative
02/12/2004CA2493737A1 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers
02/11/2004CN1473814A Intemediate for preparing alkyl-dihalogeno phenyl substituted keto-enol
02/10/2004US6689784 Controlling cell apoptosis
02/05/2004US20040024059 Novel pleuromutilin derivatives
02/05/2004US20040023806 Agrochemicals in agriculture for controlling acarids and insects and for preventing the infestation of crop plants by phytopathogenic fungi.
02/04/2004EP1385971A2 Transformation of (di)amines in the presence of a lysine oxidase and a reducing agent
02/04/2004CN1472203A Two-photon initiator, synthetic method and microprocessing technology thereof
02/03/2004US6686355 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors
02/03/2004US6685617 4-(((-1-carboxy-2-(4-((2,6-dichlorobenzoyl)amine)phenyl)ethyl) amino)carbonyl)-3-oxo-3-thiazolidinebutanoic acid, used as antagonists for cellular adhesion molecules, and administered as antiinflammatory agents
01/2004
01/29/2004WO2004009530A1 Process for production of high-purity enamines
01/28/2004CN1136203C Benzoxazine and penzothiazine derivatives and their use in pharmaceuticals
01/22/2004US20040014783 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders
01/21/2004EP1381592A1 1,4-disubstituted benzo-fused compounds
01/15/2004US20040010143 Viricides
01/14/2004EP1380306A1 Remedies for psychoneurosis
01/14/2004CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same
01/13/2004US6677378 Monoamine reuptake inhibitors for treatment of CNS disorders
01/08/2004US20040006080 Chemical compounds
01/08/2004US20040006077 Thiazine and oxazine derivatives as MMP-13 inhibitors
01/08/2004US20040006075 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
01/08/2004US20040004922 Materials for optical medium copy-protection transiently reacting to a reader beam
01/07/2004EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
01/07/2004EP1027055B1 3-carboalkoxy-2,3-dihydro-1h-phenothiazin-4(10h)-one derivatives
01/02/2004EP1375489A1 Medicinal composition containing 1,3-thiazine derivative
01/02/2004EP1373188A1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics
01/01/2004US20040002123 Detection of transmembrane potentials by optical methods
12/2003
12/31/2003WO2004000322A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
12/31/2003WO2004000321A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
12/31/2003CA2491210A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
12/24/2003WO2003107331A1 Materials for optical medium copy-protection transiently reacting to a reader beam
12/24/2003WO2003105811A2 Controlled release compositions and methods for using same
12/24/2003CA2489439A1 Materials for optical medium copy-protection transiently reacting to a reader beam
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/18/2003WO2003103569A2 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues
12/17/2003EP1206467B1 N-heterocyclic derivatives as nos inhibitors
12/17/2003CN1131209C Alkyl dihalogenated phenyl-substituted ketoenols useful as. pesticides and herbicides
12/16/2003US6664411 Heterocyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
12/16/2003US6664251 Benzothiazine derivative
12/11/2003US20030229082 Viricides
12/11/2003US20030229073 Tricyclic compounds and method of treating herpes virus
12/04/2003WO2003099800A1 An improved process for the preparation of bicyclic antidiabetic agents
12/04/2003WO2003034989A3 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
12/04/2003WO2002086138A3 Transformation of (di)amines in the presence of a lysine oxidase and a reducing agent
12/03/2003EP1015437B1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 52